Document Classification

Section Type: RESULTS

Text: 886 (23 %) patients in the candesartan and 945 (25 %) in the placebo group died (unadjusted hazard ratio 0. 91 [95 % CI 0. 83-1. 00], p = 0. 055 ; covariate adjusted 0. 90 [0. 82-0. 99], p = 0. 032), with fewer cardiovascular deaths (691 [18 %] vs 769 [20 %], unadjusted 0. 88 [0. 79-0. 97], p = 0. 012 ; covariate adjusted 0. 87 [0. 78-0. 96], p = 0. 006) and hospital admissions for CHF (757 [20 %] vs 918 [24 %], p < 0. 0001) in the candesartan group.